From Planes to Bottles: How Air Cargo Advances Cancer Care


“Air freight is an underappreciated but vital lifeline for oncology access. Behind every glass is an ecosystem of accuracy and timeliness.”

Yulia Seltaria, global director of pharmaceuticals at Healthc’Air, speaks calmly but with conviction. Her words reflect an often-overlooked reality: While awareness campaigns fill the public sphere every October, the logistical networks that enable global access to cancer treatment remain largely hidden.

Each shipment of breast cancer treatment represents more than just shipping. It’s the next step in patient care, the drugmaker’s commitment to quality, and the industry’s quiet promise never to compromise on time and temperature. This is where the human side of air cargo shines – a system that combines operational precision with empathy.

Last Mile Peril: Where Seconds and Degrees Matter

according to Alex GulenSmall and medium-sized life sciences and pharmaceutical companies in the world tiffThe greatest weakness of oncology treatment occurs in the late phase of dissemination.
“The greatest risk of temperature fluctuations occurs during the last mile of delivery – especially for pharmaceutical products that are shipped at 2-8 degrees C or room temperature controlled temperatures.” He explained. “This step often involves local distribution or direct delivery to the patient, where strict environmental control becomes more difficult to maintain.”

New cancer treatments often require very cold conditions, from -40 degrees to -196 degrees. For such processors, the risk extends to the entire supply chain. “Every delivery or delay increases the chance of a deviation.” Jillian said.

For Tiff, the solution lies in constant vision. “Our trackers provide real-time visibility and immediate alerts when a temperature deviation, delay or shock event occurs – so teams can intervene immediately to protect shipments.” he said. The company’s managed surveillance services now monitor critical drug shipments around the clock, intervening before product safety is compromised.

Every successful rescue translates directly to an outcome for the patient. Jillian pointed out BiocareA specialized logistics provider, for example: using Tive dry ice sensors, Biocare continuously tracks location and temperature, allowing early corrective action. “Each intervention represents a patient receiving timely treatment—proof that real-time monitoring translates directly to better health outcomes.” He added.

As more treatment approaches the patient, the pressure on logistics increases. “Expanding home healthcare is changing the cold chain from centralized distribution to direct delivery to the patient.” Jillian noted. “Any step outside of a controlled facility is high risk, requiring close monitoring and coordinated logistics.”

Airlines are making this change possible by expanding networks to include secondary airports and regional hubs, he added. “Reducing exposure times and ensuring treatments are safe, effective and ready to use.”

Care Delivery: The GSA Coordination Layer

you Aitken InnCEO of the company GSA International GroupThe challenge is not only technical, but also systemic. Oncology shipments move through many players—forwarders, handlers, airlines, regulators—and any misalignment can threaten integrity.

“Our teams know that they’re not just managing shipments, they’re managing the critical care of people waiting in hospitals or at home.” Sarah said.

The GSA International Group manages oncology and other life sciences shipments for many airline partners worldwide. Cooperation with the company health care It enhances these capabilities through coordinated standard operating procedures, proactive monitoring, and contingency planning.

Sarai points out that many of the industry’s risks stem from inconsistency. Infrastructure, regulatory interpretation and availability of trained staff vary between regions. he said. “This is where GSAs can make a difference—by anticipating issues, improving routes, and coordinating with partners before deviations occur.”

Transmissions between processors or transmission methods are the weakest links. He added that the GSAs serve as stability factors for the chain: ensuring certified capacity, rapid transit to temperature-controlled areas, and clear communication between all parties.

On Earth: Accuracy of Transactions and Responsibility

at the SwissportPharmacies are not a single commodity but the backbone of large operations. “Air cargo for pharmaceuticals and life sciences is at the heart of our pharmaceutical warehouses, for example in Basel, Switzerland. About 65 percent of their export volume is pharmaceutical products.” he said Dirk GovartsCompany CEO and Global Shipping Head for Europe, Middle East, Africa and India.

Swissport’s 23 authorized medical centers – including centers in Basel, Brussels, Amsterdam, Nairobi and Tokyo Narita – are designed around traceability and temperature control. The facility has multiple temperature zones (+15°C to +25°C, +2°C to +8°C, and -20°C) and continuous environmental monitoring.

“The main danger is heat dissipation.” Govarts said. “We minimize this by fully tracking every stage of processing and continuously monitoring temperatures in all storage areas.”

Swissport do + connect The corridor, launched in Basel in 2024, allows cargo with a pre-condition of +2°C to +8°C, reducing the need for truck operations between warehouses and aircraft. “These facilities reduce additional truck movements, reducing CO2 emissions while improving temperature stability.” he said.

Vision is also key. Customers receive automatic updates through Swissport’s CiQ platform and are immediately notified if any temperature deviations occur. However, Govarts believes that culture is just as important as technology. “All shipping staff receive regular training on how to administer medications. Our fair culture helps teams understand that every shipment can be a life-saving treatment.”

future investment objective League and ChicagoAs the demands of gene therapy logistics accelerate, Swissport expands its ability to handle extremely low temperatures (-60°C and below).

Airlines in Oncology Logistics Center

you Lufthansa CargoLife sciences and pharma logistics are not seasonal focuses but strategic pillars. “Life sciences and pharmaceuticals form a strategic pillar of Lufthansa Cargo’s business and represent one of its fastest growing sectors.” Ort Wertz, director of global sales and product management at Lufthansa Cargo, said.

Every year the company handles large volumes of vaccines, diagnostics and oncology drugs through a global network of more than 230 pharmaceutical terminals – 30 CEIV Pharma certified and six GDPR certified.

A final operation shows the necessary accuracy. “The leading breast cancer treatment is regularly flown under active climate control conditions from Dublin to Tokyo, first to Frankfurt on an Airbus A321F, then to Narita on a Boeing 777F.” The airline took notice. Both flights use Envirotainer units under constant surveillance by Lufthansa’s drug control tower.

“Ensuring the safety of heat-sensitive drugs during air transport requires careful coordination at all stages of handling.” Wertz said.

Lufthansa Cargo addresses these challenges through clearly defined processes, proven infrastructure and continuous innovation, both for temperature-controlled cargo and actively supported cargo. The carrier uses pre-conditioned storage, thermal covers, exposure time calculators, and sensor-enabled ULDs that transmit live data.

Inc LCCevo The modernization project – a €600 million investment scheduled to be completed by 2030 – will transform Frankfurt into the most advanced pharmaceutical logistics center in Europe, fully integrated with smart monitoring and automation.

Beyond technology, Wirtz highlights its role in expanding access. “Through Brussels Airlines’ strong network in Africa, Lufthansa Cargo connects pharmaceutical manufacturers to remote areas, helping to ensure that essential treatments reach the patients who depend on them.”

From Planes to Bottles: How Air Cargo Advances Cancer Care
From Planes to Bottles: How Air Cargo Advances Cancer Care

Resistance remains central. “Recent months have shown once again how important flexibility and transparency are to maintaining reliable pharmaceutical logistics.” The airline added.

Sustainability lies alongside reliability. “For Lufthansa Cargo, climate protection and product safety go hand in hand.” The carrier is increasing efficiency and sustainability through fleet and facility modernization, certified environmental stewardship, and sustainable aviation fuel use, all of which contribute to the long-term goal of climate-neutral operations.

Looking to the future, Wirtz expects increased demand for rapid, temperature-sensitive transport of advanced therapies. “By 2030, air cargo will remain essential to providing advanced cancer treatments globally.” The airline said.

Bridging Access and Awareness

Healthc’Air is at the intersection of technology, compliance and compassion. For Julia Seltaria, every operational criterion begins with empathy. “Air transport can only be as strong as the weakest link in the chain.” she said “That’s why we at Healthc’Air are focused on building smart corridors for air medicine – connecting approved terminals with trained partners and harmonized standard operating procedures.”

These lines support more than off-the-shelf drugs. “Air freight supports every stage of healthcare – from biological samples for genomic testing to research drugs and diagnostic reagents.” she explained.

Air Health Philosophy, “From Plane to Bottle”Reflects the shift towards fully connected logistics – where data visibility and human responsibility move hand in hand. “Every oncology treatment transfer is more than just temperature data and transfer miles—it’s an opportunity for someone to continue treatment and live.”

Seletaria sees awareness initiatives as more than just symbolic. “People move medicine, not systems — and awareness, especially during Breast Cancer Awareness Month, reminds us that behind every box there is someone who has hope.”

Predictive supply chains and human focus

For Gulen in the Tiv, future change will depend on intelligence, not reaction. “The next wave of reliability will come from predictive, not reactive, cold chain management.” he said.

Real-time IoT sensors will still be necessary, but their value will deepen as AI analyzes millions of data points to predict risk patterns and automate interventions. “These innovations will help maintain drug safety and ensure that every patient receives their treatment as intended.”

Across the ecosystem – from Lufthansa’s digital medication map to Swissport’s real-time management data, from GSAs’ network monitoring to Healthc’Air’s corridor validation – a similar shift is occurring: transforming air cargo from a mode of transportation to an active care network.

Oncology logistics is no longer a hidden specialty. Each innovation in surveillance, infrastructure and collaboration represents a thread in the larger tapestry that holds together universal access to treatment.

Risks are not measured in tons, but in lives: the mother waiting for her next dose, the researcher who reached the experimental bar, the hospital technician who confirms the stability of the storage data.

As an industry benchmark Breast Cancer Awareness MonthIts quietest work may also be its most impressive—ensuring that every glass delivered to air freight is safe, cool and full of hope.



https://timesofcargo.com/

Post Comment

You May Have Missed